Dr Lauren Pate Lehmann, MD - Medicare Psychiatry in Salem, VA

Dr Lauren Pate Lehmann, MD is a medicare enrolled "Psychiatry & Neurology - Psychiatry" physician in Salem, Virginia. She went to Baylor College Of Medicine and graduated in 1983 and has 41 years of diverse experience with area of expertise as Psychiatry. She is a member of the group practice Centra Medical Group Llc, Sentara Medical Group and her current practice location is 1970 Roanoke Blvd, Psychiatry 116a4, Salem, Virginia. You can reach out to her office (for appointments etc.) via phone at (540) 982-2463.

Dr Lauren Pate Lehmann is licensed to practice in Virginia (license number 48990) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1447213210.

Contact Information

Dr Lauren Pate Lehmann, MD
1970 Roanoke Blvd, Psychiatry 116a4,
Salem, VA 24153-6404
(540) 982-2463
(540) 983-1078



Physician's Profile

Full NameDr Lauren Pate Lehmann
GenderFemale
SpecialityPsychiatry
Experience41 Years
Location1970 Roanoke Blvd, Salem, Virginia
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Lauren Pate Lehmann attended and graduated from Baylor College Of Medicine in 1983
  NPI Data:
  • NPI Number: 1447213210
  • Provider Enumeration Date: 04/11/2006
  • Last Update Date: 12/29/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 4880874742
  • Enrollment ID: I20110209000698

Medical Identifiers

Medical identifiers for Dr Lauren Pate Lehmann such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1447213210NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2084P0800XPsychiatry & Neurology - Psychiatry 48990 (Virginia)Primary
2084A0401XPsychiatry & Neurology - Addiction Medicine 0101048990 (Virginia)Secondary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Sentara Williamsburg Regional Medical CenterWilliamsburg, VAHospital
Sentara Princess Anne HospitalVirginia beach, VAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Centra Medical Group Llc4789606088603
Sentara Medical Group89219039231058

News Archive

DVS Sciences announces introduction of new products for single cell analysis

DVS Sciences, Inc., a privately held innovator of novel multi-parameter single-cell analyzers and reagents for biological research, today announced the introduction of the new CyTOF 2 Mass Cytometer and new MaxPar Panel Kits designed specifically for simultaneous high-parameter single cell analysis.

Secretary of state nominee Sen. John Kerry would continue administration's focus on global health, food security, Devex reports

"President Barack Obama's 'perfect choice' for state secretary" - Sen. John Kerry (D-Mass.) - "is not only expected to advance the administration's agenda on global health and food security, but he might also lend new heft to efforts to rein in climate change, one of Kerry's long-time priorities, with a team of advisers that is expected to include several with a background in international development," Devex reports.

Salt Association hits back at "Sid the Slug" campaign

The Salt Manufacturers Association has lodged a complaint with the Advertising Standards Authority over the use of a cartoon slug to front a new £4 million salt restriction campaign.

Democrats awaiting MedPAC report to begin discussing Medicare physician payment reform

Members of the Medicare Payment Advisory Commission on Thursday will testify before House and Senate committees with jurisdiction over Medicare about their annual report, which likely will include recommendations on revisions to the Medicare physician reimbursement formula, the Palm Beach Post reports.

Raptor Pharmaceuticals initiates phase IIa clinical study for Convivia

Raptor Pharmaceuticals Corp. has announced that its clinical development subsidiary, Bennu Pharmaceuticals Inc. , has initiated the Company's first clinical-stage program after dosing the first cohort in a Phase IIa study of oral 4-methylpyrazole ("4-MP") in subjects with ALDH2 deficiency, or ethanol intolerance, as the initial development stage of its Convivia program.

Read more Medical News

› Verified 1 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Lauren Pate Lehmann allows following entities to bill medicare on her behalf.
Entity NameSentara Medical Group
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1265485270
PECOS PAC ID: 8921903923
Enrollment ID: O20031203000466

News Archive

DVS Sciences announces introduction of new products for single cell analysis

DVS Sciences, Inc., a privately held innovator of novel multi-parameter single-cell analyzers and reagents for biological research, today announced the introduction of the new CyTOF 2 Mass Cytometer and new MaxPar Panel Kits designed specifically for simultaneous high-parameter single cell analysis.

Secretary of state nominee Sen. John Kerry would continue administration's focus on global health, food security, Devex reports

"President Barack Obama's 'perfect choice' for state secretary" - Sen. John Kerry (D-Mass.) - "is not only expected to advance the administration's agenda on global health and food security, but he might also lend new heft to efforts to rein in climate change, one of Kerry's long-time priorities, with a team of advisers that is expected to include several with a background in international development," Devex reports.

Salt Association hits back at "Sid the Slug" campaign

The Salt Manufacturers Association has lodged a complaint with the Advertising Standards Authority over the use of a cartoon slug to front a new £4 million salt restriction campaign.

Democrats awaiting MedPAC report to begin discussing Medicare physician payment reform

Members of the Medicare Payment Advisory Commission on Thursday will testify before House and Senate committees with jurisdiction over Medicare about their annual report, which likely will include recommendations on revisions to the Medicare physician reimbursement formula, the Palm Beach Post reports.

Raptor Pharmaceuticals initiates phase IIa clinical study for Convivia

Raptor Pharmaceuticals Corp. has announced that its clinical development subsidiary, Bennu Pharmaceuticals Inc. , has initiated the Company's first clinical-stage program after dosing the first cohort in a Phase IIa study of oral 4-methylpyrazole ("4-MP") in subjects with ALDH2 deficiency, or ethanol intolerance, as the initial development stage of its Convivia program.

Read more Medical News

› Verified 1 days ago

Entity NameMcv Associated Physicians
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1710959457
PECOS PAC ID: 4385542117
Enrollment ID: O20031230000559

News Archive

DVS Sciences announces introduction of new products for single cell analysis

DVS Sciences, Inc., a privately held innovator of novel multi-parameter single-cell analyzers and reagents for biological research, today announced the introduction of the new CyTOF 2 Mass Cytometer and new MaxPar Panel Kits designed specifically for simultaneous high-parameter single cell analysis.

Secretary of state nominee Sen. John Kerry would continue administration's focus on global health, food security, Devex reports

"President Barack Obama's 'perfect choice' for state secretary" - Sen. John Kerry (D-Mass.) - "is not only expected to advance the administration's agenda on global health and food security, but he might also lend new heft to efforts to rein in climate change, one of Kerry's long-time priorities, with a team of advisers that is expected to include several with a background in international development," Devex reports.

Salt Association hits back at "Sid the Slug" campaign

The Salt Manufacturers Association has lodged a complaint with the Advertising Standards Authority over the use of a cartoon slug to front a new £4 million salt restriction campaign.

Democrats awaiting MedPAC report to begin discussing Medicare physician payment reform

Members of the Medicare Payment Advisory Commission on Thursday will testify before House and Senate committees with jurisdiction over Medicare about their annual report, which likely will include recommendations on revisions to the Medicare physician reimbursement formula, the Palm Beach Post reports.

Raptor Pharmaceuticals initiates phase IIa clinical study for Convivia

Raptor Pharmaceuticals Corp. has announced that its clinical development subsidiary, Bennu Pharmaceuticals Inc. , has initiated the Company's first clinical-stage program after dosing the first cohort in a Phase IIa study of oral 4-methylpyrazole ("4-MP") in subjects with ALDH2 deficiency, or ethanol intolerance, as the initial development stage of its Convivia program.

Read more Medical News

› Verified 1 days ago

Entity NameRiverside Physician Services Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1194929026
PECOS PAC ID: 5092608448
Enrollment ID: O20040207000400

News Archive

DVS Sciences announces introduction of new products for single cell analysis

DVS Sciences, Inc., a privately held innovator of novel multi-parameter single-cell analyzers and reagents for biological research, today announced the introduction of the new CyTOF 2 Mass Cytometer and new MaxPar Panel Kits designed specifically for simultaneous high-parameter single cell analysis.

Secretary of state nominee Sen. John Kerry would continue administration's focus on global health, food security, Devex reports

"President Barack Obama's 'perfect choice' for state secretary" - Sen. John Kerry (D-Mass.) - "is not only expected to advance the administration's agenda on global health and food security, but he might also lend new heft to efforts to rein in climate change, one of Kerry's long-time priorities, with a team of advisers that is expected to include several with a background in international development," Devex reports.

Salt Association hits back at "Sid the Slug" campaign

The Salt Manufacturers Association has lodged a complaint with the Advertising Standards Authority over the use of a cartoon slug to front a new £4 million salt restriction campaign.

Democrats awaiting MedPAC report to begin discussing Medicare physician payment reform

Members of the Medicare Payment Advisory Commission on Thursday will testify before House and Senate committees with jurisdiction over Medicare about their annual report, which likely will include recommendations on revisions to the Medicare physician reimbursement formula, the Palm Beach Post reports.

Raptor Pharmaceuticals initiates phase IIa clinical study for Convivia

Raptor Pharmaceuticals Corp. has announced that its clinical development subsidiary, Bennu Pharmaceuticals Inc. , has initiated the Company's first clinical-stage program after dosing the first cohort in a Phase IIa study of oral 4-methylpyrazole ("4-MP") in subjects with ALDH2 deficiency, or ethanol intolerance, as the initial development stage of its Convivia program.

Read more Medical News

› Verified 1 days ago

Entity NameCmh Physician Services Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1194760645
PECOS PAC ID: 3779551445
Enrollment ID: O20040921000171

News Archive

DVS Sciences announces introduction of new products for single cell analysis

DVS Sciences, Inc., a privately held innovator of novel multi-parameter single-cell analyzers and reagents for biological research, today announced the introduction of the new CyTOF 2 Mass Cytometer and new MaxPar Panel Kits designed specifically for simultaneous high-parameter single cell analysis.

Secretary of state nominee Sen. John Kerry would continue administration's focus on global health, food security, Devex reports

"President Barack Obama's 'perfect choice' for state secretary" - Sen. John Kerry (D-Mass.) - "is not only expected to advance the administration's agenda on global health and food security, but he might also lend new heft to efforts to rein in climate change, one of Kerry's long-time priorities, with a team of advisers that is expected to include several with a background in international development," Devex reports.

Salt Association hits back at "Sid the Slug" campaign

The Salt Manufacturers Association has lodged a complaint with the Advertising Standards Authority over the use of a cartoon slug to front a new £4 million salt restriction campaign.

Democrats awaiting MedPAC report to begin discussing Medicare physician payment reform

Members of the Medicare Payment Advisory Commission on Thursday will testify before House and Senate committees with jurisdiction over Medicare about their annual report, which likely will include recommendations on revisions to the Medicare physician reimbursement formula, the Palm Beach Post reports.

Raptor Pharmaceuticals initiates phase IIa clinical study for Convivia

Raptor Pharmaceuticals Corp. has announced that its clinical development subsidiary, Bennu Pharmaceuticals Inc. , has initiated the Company's first clinical-stage program after dosing the first cohort in a Phase IIa study of oral 4-methylpyrazole ("4-MP") in subjects with ALDH2 deficiency, or ethanol intolerance, as the initial development stage of its Convivia program.

Read more Medical News

› Verified 1 days ago

Entity NameSouthside Community Services Board
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1700890761
PECOS PAC ID: 4284660507
Enrollment ID: O20050708000612

News Archive

DVS Sciences announces introduction of new products for single cell analysis

DVS Sciences, Inc., a privately held innovator of novel multi-parameter single-cell analyzers and reagents for biological research, today announced the introduction of the new CyTOF 2 Mass Cytometer and new MaxPar Panel Kits designed specifically for simultaneous high-parameter single cell analysis.

Secretary of state nominee Sen. John Kerry would continue administration's focus on global health, food security, Devex reports

"President Barack Obama's 'perfect choice' for state secretary" - Sen. John Kerry (D-Mass.) - "is not only expected to advance the administration's agenda on global health and food security, but he might also lend new heft to efforts to rein in climate change, one of Kerry's long-time priorities, with a team of advisers that is expected to include several with a background in international development," Devex reports.

Salt Association hits back at "Sid the Slug" campaign

The Salt Manufacturers Association has lodged a complaint with the Advertising Standards Authority over the use of a cartoon slug to front a new £4 million salt restriction campaign.

Democrats awaiting MedPAC report to begin discussing Medicare physician payment reform

Members of the Medicare Payment Advisory Commission on Thursday will testify before House and Senate committees with jurisdiction over Medicare about their annual report, which likely will include recommendations on revisions to the Medicare physician reimbursement formula, the Palm Beach Post reports.

Raptor Pharmaceuticals initiates phase IIa clinical study for Convivia

Raptor Pharmaceuticals Corp. has announced that its clinical development subsidiary, Bennu Pharmaceuticals Inc. , has initiated the Company's first clinical-stage program after dosing the first cohort in a Phase IIa study of oral 4-methylpyrazole ("4-MP") in subjects with ALDH2 deficiency, or ethanol intolerance, as the initial development stage of its Convivia program.

Read more Medical News

› Verified 1 days ago

Entity NameCentra Medical Group Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1649228966
PECOS PAC ID: 4789606088
Enrollment ID: O20051230000147

News Archive

DVS Sciences announces introduction of new products for single cell analysis

DVS Sciences, Inc., a privately held innovator of novel multi-parameter single-cell analyzers and reagents for biological research, today announced the introduction of the new CyTOF 2 Mass Cytometer and new MaxPar Panel Kits designed specifically for simultaneous high-parameter single cell analysis.

Secretary of state nominee Sen. John Kerry would continue administration's focus on global health, food security, Devex reports

"President Barack Obama's 'perfect choice' for state secretary" - Sen. John Kerry (D-Mass.) - "is not only expected to advance the administration's agenda on global health and food security, but he might also lend new heft to efforts to rein in climate change, one of Kerry's long-time priorities, with a team of advisers that is expected to include several with a background in international development," Devex reports.

Salt Association hits back at "Sid the Slug" campaign

The Salt Manufacturers Association has lodged a complaint with the Advertising Standards Authority over the use of a cartoon slug to front a new £4 million salt restriction campaign.

Democrats awaiting MedPAC report to begin discussing Medicare physician payment reform

Members of the Medicare Payment Advisory Commission on Thursday will testify before House and Senate committees with jurisdiction over Medicare about their annual report, which likely will include recommendations on revisions to the Medicare physician reimbursement formula, the Palm Beach Post reports.

Raptor Pharmaceuticals initiates phase IIa clinical study for Convivia

Raptor Pharmaceuticals Corp. has announced that its clinical development subsidiary, Bennu Pharmaceuticals Inc. , has initiated the Company's first clinical-stage program after dosing the first cohort in a Phase IIa study of oral 4-methylpyrazole ("4-MP") in subjects with ALDH2 deficiency, or ethanol intolerance, as the initial development stage of its Convivia program.

Read more Medical News

› Verified 1 days ago

Entity NameUva Community Health Medical Group, Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1023483567
PECOS PAC ID: 4688587967
Enrollment ID: O20110311000151

News Archive

DVS Sciences announces introduction of new products for single cell analysis

DVS Sciences, Inc., a privately held innovator of novel multi-parameter single-cell analyzers and reagents for biological research, today announced the introduction of the new CyTOF 2 Mass Cytometer and new MaxPar Panel Kits designed specifically for simultaneous high-parameter single cell analysis.

Secretary of state nominee Sen. John Kerry would continue administration's focus on global health, food security, Devex reports

"President Barack Obama's 'perfect choice' for state secretary" - Sen. John Kerry (D-Mass.) - "is not only expected to advance the administration's agenda on global health and food security, but he might also lend new heft to efforts to rein in climate change, one of Kerry's long-time priorities, with a team of advisers that is expected to include several with a background in international development," Devex reports.

Salt Association hits back at "Sid the Slug" campaign

The Salt Manufacturers Association has lodged a complaint with the Advertising Standards Authority over the use of a cartoon slug to front a new £4 million salt restriction campaign.

Democrats awaiting MedPAC report to begin discussing Medicare physician payment reform

Members of the Medicare Payment Advisory Commission on Thursday will testify before House and Senate committees with jurisdiction over Medicare about their annual report, which likely will include recommendations on revisions to the Medicare physician reimbursement formula, the Palm Beach Post reports.

Raptor Pharmaceuticals initiates phase IIa clinical study for Convivia

Raptor Pharmaceuticals Corp. has announced that its clinical development subsidiary, Bennu Pharmaceuticals Inc. , has initiated the Company's first clinical-stage program after dosing the first cohort in a Phase IIa study of oral 4-methylpyrazole ("4-MP") in subjects with ALDH2 deficiency, or ethanol intolerance, as the initial development stage of its Convivia program.

Read more Medical News

› Verified 1 days ago

Entity NameGreenbrook Tms Roanoke
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1427561059
PECOS PAC ID: 2769742766
Enrollment ID: O20180213001650

News Archive

DVS Sciences announces introduction of new products for single cell analysis

DVS Sciences, Inc., a privately held innovator of novel multi-parameter single-cell analyzers and reagents for biological research, today announced the introduction of the new CyTOF 2 Mass Cytometer and new MaxPar Panel Kits designed specifically for simultaneous high-parameter single cell analysis.

Secretary of state nominee Sen. John Kerry would continue administration's focus on global health, food security, Devex reports

"President Barack Obama's 'perfect choice' for state secretary" - Sen. John Kerry (D-Mass.) - "is not only expected to advance the administration's agenda on global health and food security, but he might also lend new heft to efforts to rein in climate change, one of Kerry's long-time priorities, with a team of advisers that is expected to include several with a background in international development," Devex reports.

Salt Association hits back at "Sid the Slug" campaign

The Salt Manufacturers Association has lodged a complaint with the Advertising Standards Authority over the use of a cartoon slug to front a new £4 million salt restriction campaign.

Democrats awaiting MedPAC report to begin discussing Medicare physician payment reform

Members of the Medicare Payment Advisory Commission on Thursday will testify before House and Senate committees with jurisdiction over Medicare about their annual report, which likely will include recommendations on revisions to the Medicare physician reimbursement formula, the Palm Beach Post reports.

Raptor Pharmaceuticals initiates phase IIa clinical study for Convivia

Raptor Pharmaceuticals Corp. has announced that its clinical development subsidiary, Bennu Pharmaceuticals Inc. , has initiated the Company's first clinical-stage program after dosing the first cohort in a Phase IIa study of oral 4-methylpyrazole ("4-MP") in subjects with ALDH2 deficiency, or ethanol intolerance, as the initial development stage of its Convivia program.

Read more Medical News

› Verified 1 days ago

Entity NameGreenbrook Tms Christiansburg Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1558862953
PECOS PAC ID: 2062777600
Enrollment ID: O20180531000737

News Archive

DVS Sciences announces introduction of new products for single cell analysis

DVS Sciences, Inc., a privately held innovator of novel multi-parameter single-cell analyzers and reagents for biological research, today announced the introduction of the new CyTOF 2 Mass Cytometer and new MaxPar Panel Kits designed specifically for simultaneous high-parameter single cell analysis.

Secretary of state nominee Sen. John Kerry would continue administration's focus on global health, food security, Devex reports

"President Barack Obama's 'perfect choice' for state secretary" - Sen. John Kerry (D-Mass.) - "is not only expected to advance the administration's agenda on global health and food security, but he might also lend new heft to efforts to rein in climate change, one of Kerry's long-time priorities, with a team of advisers that is expected to include several with a background in international development," Devex reports.

Salt Association hits back at "Sid the Slug" campaign

The Salt Manufacturers Association has lodged a complaint with the Advertising Standards Authority over the use of a cartoon slug to front a new £4 million salt restriction campaign.

Democrats awaiting MedPAC report to begin discussing Medicare physician payment reform

Members of the Medicare Payment Advisory Commission on Thursday will testify before House and Senate committees with jurisdiction over Medicare about their annual report, which likely will include recommendations on revisions to the Medicare physician reimbursement formula, the Palm Beach Post reports.

Raptor Pharmaceuticals initiates phase IIa clinical study for Convivia

Raptor Pharmaceuticals Corp. has announced that its clinical development subsidiary, Bennu Pharmaceuticals Inc. , has initiated the Company's first clinical-stage program after dosing the first cohort in a Phase IIa study of oral 4-methylpyrazole ("4-MP") in subjects with ALDH2 deficiency, or ethanol intolerance, as the initial development stage of its Convivia program.

Read more Medical News

› Verified 1 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Lauren Pate Lehmann is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Lauren Pate Lehmann, MD
1970 Roanoke Blvd, Psychiatry 116a4,
Salem, VA 24153-6404

Ph: (540) 982-2463
Dr Lauren Pate Lehmann, MD
1970 Roanoke Blvd, Psychiatry 116a4,
Salem, VA 24153-6404

Ph: (540) 982-2463

News Archive

DVS Sciences announces introduction of new products for single cell analysis

DVS Sciences, Inc., a privately held innovator of novel multi-parameter single-cell analyzers and reagents for biological research, today announced the introduction of the new CyTOF 2 Mass Cytometer and new MaxPar Panel Kits designed specifically for simultaneous high-parameter single cell analysis.

Secretary of state nominee Sen. John Kerry would continue administration's focus on global health, food security, Devex reports

"President Barack Obama's 'perfect choice' for state secretary" - Sen. John Kerry (D-Mass.) - "is not only expected to advance the administration's agenda on global health and food security, but he might also lend new heft to efforts to rein in climate change, one of Kerry's long-time priorities, with a team of advisers that is expected to include several with a background in international development," Devex reports.

Salt Association hits back at "Sid the Slug" campaign

The Salt Manufacturers Association has lodged a complaint with the Advertising Standards Authority over the use of a cartoon slug to front a new £4 million salt restriction campaign.

Democrats awaiting MedPAC report to begin discussing Medicare physician payment reform

Members of the Medicare Payment Advisory Commission on Thursday will testify before House and Senate committees with jurisdiction over Medicare about their annual report, which likely will include recommendations on revisions to the Medicare physician reimbursement formula, the Palm Beach Post reports.

Raptor Pharmaceuticals initiates phase IIa clinical study for Convivia

Raptor Pharmaceuticals Corp. has announced that its clinical development subsidiary, Bennu Pharmaceuticals Inc. , has initiated the Company's first clinical-stage program after dosing the first cohort in a Phase IIa study of oral 4-methylpyrazole ("4-MP") in subjects with ALDH2 deficiency, or ethanol intolerance, as the initial development stage of its Convivia program.

Read more News

› Verified 1 days ago


Psychiatry & Neurology Doctors in Salem, VA

Dr. Enrique Perez, MD
Psychiatry & Neurology
Medicare: Medicare Enrolled
Practice Location: 1970 Roanoke Blvd, Salem, VA 24153
Phone: 540-982-2463    Fax: 540-982-2463
John Joe Yazel, M.D.
Psychiatry & Neurology
Medicare: Not Enrolled in Medicare
Practice Location: 1970 Roanoke Blvd, Salem, VA 24153
Phone: 540-982-2463    Fax: 540-983-1086
Dr. Sachinder Vasudeva, MD
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 1970 Roanoke Blvd, #116 B, Salem, VA 24153
Phone: 540-982-2463    Fax: 540-983-1086
Dr. Brian Edwin Wood, D.O.
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 1902 Braeburn Dr Ste 130, Salem, VA 24153
Phone: 540-444-0460    
Dr. Richard Preston Leggett, MD
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 1906 Braeburn Dr, Salem, VA 24153
Phone: 540-444-0460    Fax: 540-444-0479
Dr. Harleen Gill, M.D.
Psychiatry & Neurology
Medicare: Not Enrolled in Medicare
Practice Location: 1970 Roanoke Blvd, Salem Va Medical Center, Salem, VA 24153
Phone: 540-982-2463    
Dr. Amir A. Khan, MD
Psychiatry & Neurology
Medicare: Not Enrolled in Medicare
Practice Location: 1970 Roanoke Blvd, Mhbl, Salem, VA 24153
Phone: 540-982-2463    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.